Etanercept as a Possible Trigger of Fatal Pulmonary Fibrosis

Piña, J.M. Díez; Gómez, Óscar Vázquez; Alises, Sagrario Mayoralas; Jiménez, José D. García; Álvarez, Dolores Álvaro; Bolado, M. Paz Rodríguez

doi:10.1016/s1579-2129(08)60067-1

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Etanercept as a Possible Trigger of Fatal Pulmonary Fibrosis

Cited by 3 publications

References 8 publications

Early instauration granulomatous pneumonitis associated with use of etanercept in seronegative spondyloarthropathy: Case report

Early instauration granulomatous pneumonitis associated with use of etanercept in seronegative spondyloarthropathy: Case report

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

New Developments in the Therapy of Pulmonary Fibrosis

Contact Info

Product

Resources

About